ABSTRACT Effective activation of a recipient oocyte and its compatibility with the 1 nuclear donor are critical to the successful nuclear reprogramming during nuclear 2 transfer. We designed a series of experiments using various activation methods to 3 determine the optimum activation efficiency of bovine oocytes. We then performed 4 nuclear transfer (NT) of embryonic and somatic cells into cytoplasts presumably at G1/S 5 phase (with prior activation) or at metaphase II (M II, without prior activation). Oocytes 6 at 24 h of maturation in vitro were activated with various combinations of calcium 7 ionophore A23187 (A187) (5 µM, 5 min), electric pulse (EP), ethanol (7%, 7 min), 8 cycloheximide (CHX) (10 µg/ml, 6 h), and then cultured in cytochalasin D (CD) for a 9 total of 18 h. Through a series of experiments (Expt 1-4), an improved activation 10 protocol (A187/EP/CHX/CD) was identified and used for comparison of NT efficiency of 11 embryonic vs. somatic donor cells (Expt 5). When embryonic cells from morula and 12 blastocysts were used as nuclear donors, a significantly higher rate of blastocyst 13 development from cloned embryos was obtained with G1/S phase cytoplasts than with M 14 II-phase cytoplasts (36% vs. 11%, P<0.05). In contrast, when skin fibroblasts were used 15 as donor cells, the use of an M II cytoplast (vs. G1/S phase) was imperative for blastocyst 16 development (30% vs. 6%, P<0.05). Differential staining showed that parthenogenetic, 17 embryonic, and somatic cloned blastocysts contained 26%, 29% and 33% presumptive 18 inner cell mass (ICM) cells, respectively, which is similar to that of frozen-thawed in vivo 19 embryos at a comparable developmental stage (23%). These data indicate that embryonic 20 and somatic nuclei require different recipient cytoplast environment for 21 remodeling/reprogramming, and this is likely due to the different cell cycle stage and 22 profiles of molecular differentiation of the transferred donor nuclei. 23 24 3
to an improved developmental competence of the resultant embryos (Campbell et al., 12 1994 (Campbell et al., 12 , 1996 . oocytes were sequentially activated with A187 at 24 hpm, EP at 25 hpm, then cultured in 7 CHX for 6 h, followed by two electric pulses (EP) 30 min apart at 31 hpm 8 (A187/EP/CHX/EPx2). In Treatment B oocytes were stimulated as for Treatment A 9 except that EP stimulation was given at 24 hpm instead of A187 (EP/EP/CHX/EPx2). In 10 Treatment C, oocytes were activated with EP at 24 hpm, ETOH at 25 hpm, followed by 11 the same procedures as for treatments A and B (EP/ETOH/CHX/EPx2). In Treatment D, 12 oocytes were treated with A23187 at 24 hpm, EP, 1.0 kV/cm, 90 µsec at 25 hpm, CHX 13 for 6 h and CD for 18 h (A187/EP90/CHX/CD). Treatment E was a non-stimulation 14 control (Table 1) . 15 (A187/EP45/CHX/CD) and C (A187/EP60/CHX/CD), respectively. Treatment E was 22 conducted as for Treatment A but without CD incubation (A187/EP/CHX) ( Table 2) . 23 In NT with embryonic cells, Treatment A was NT into pre-activated cytoplasts 6 (A187/EP/CHX/NT) while Treatment B was NT into a cytoplast without prior activation 7 (MII/NT/A187/EP/CHX) ( Table 5) . 8
When somatic nuclei from skin fibroblasts were used as the donors, NT with pre-9 activated (Treatment C) and metaphase II (Treatment D) cytoplasts was completed as 10 described above (Table 5) . Small donor cells with an approximate diameter of 12-15 µm 11 were allocated for transfer into the perivitelline space of enucleated oocytes (Vignon et  12 al., 1998). Somatic donor cell-cytoplasm pairs were fused by applying two direct current 13 pulses at 2.0 kV/cm for a duration of 10 µsec/each pulse. Following the completion of 14 electric fusion, there was also an 15 min incubation at room temperature before activation 15 with the optimal regime of A187/EP/CHX was applied. 16
Differential staining 17
Embryos were allowed to develop to Day 8. Early blastocysts (BL), regular BL, 18 expanded BL and hatched BL were harvested from parthenogenetic, cloned and in vivo 19 produced embryos. Expanded and hatched BLs were subjected to differential staining. 20
After removal of the zona pellucida, embryos were treated with 10 mM TNBS for 10 min 21 at 4°C, washed 3 times in M 2 -BSA and incubated in 0.1 mg/ml anti-DNP-BSA for 10 22 min at 39°C, washed in M 2 -BSA again to remove surplus antibody, then treated by a 12 23 min incubation with guinea pig complement solution and 0.25 mg/ml propidium iodide. 1
The embryos were then stained with 0.5 mg/ml Hoechst 33258 in ethanol for at least 1 h 2 to distinguish presumptive inner cell mass (ICM) whose nuclei stained blue. Presumptive 3 trophectoderm (TE) cells were stained by both propidium and Hoechst 33258, and 4 differentially indicated by a pink stain. Embryos were mounted and gently squashed 5 under a cover slip for counting of nuclei under fluorescent microscopy. 6
Statistical Analyses 7
Proportions of embryos reaching cleavage and developing to the blastocyst stage 8 from various treatments within each experiment were analyzed by Chi-square (Snedecor 9
and Cochran, 1980) or student's t-test. The mean number of nuclei for each embryo was 10 compared by one-way ANOVA. The P values less than 0.05 are considered as significant 11 between the treatments. 12
RESULTS

13
Experiment 1 14
After in vitro maturation of oocytes for 20 h, cumulus cells had expanded as 15 shown in Fig 1. A. Following parthenogenetic activation, oocytes usually cleaved to the 16 4-8 cell stage at 44-48 hr of in vitro culture, and further developed to compacted morula 17 (Fig 1.B) on Day 4, and to expanding blastocysts (Fig 1.C) on Day 8 in accordance to the 18 developmental pace expected for in vitro fertilized embryos. The proportion of 19 degenerated oocytes following activation in Treatments B (27%), and D (38%) were 20 significantly higher than in Treatments A (4%), C (4%) and control E (0%) (P<0.05). 21
Oocyte degeneration frequently took place before two electric pulses were applied at 31 22 hpm. Among the survived oocytes in Treatments A, B, C, and D, the oocytes with good 23 quality were selected for continuous in vitro culture. There was no difference among 1 Treatments A, B, or C in terms of cleavage and blastocyst development after culture in 2 vitro, and no difference among Treatment A, B, C, and D for the overall rate of blastocyst 3 development (Table 1) . Despite the high percentage of oocyte lysis in Treatment D when 4 compared to Treatments A, B and C, a significant higher rate of cleavage to 2-8 cells 5
(74% vs. 42-53%, P<0.05) and subsequent embryonic development to blastocyst stage 6 (31% vs. 8-14%, P<0.05) ( Table 1) were observed. In the control group (Treatment E), 7 11% of oocytes underwent spontaneous activation and cleavage to the 2-8 cell stage, but 8 no further development was observed. Thereafter, experiments were specifically 9 designed to determine whether the higher degree of oocyte lysis was due to the duration 10 of the EP and cytochalasin incubation (Exp.2), or if the development was improved by 11 the cytochalasin treatment (Exp. 3). 12
Experiment 2 13
This experiment was designed to test if a longer duration of electrical pulse 14 resulted in a significantly higher incidence of oocyte lysis. As shown in Table 2 , when 15 1.2 kV/cm was applied and the duration was increased from 30 µsec in Treatment A to 45 16 µsec in Treatment B, 11% and 17%, respectively, of the oocytes were lysed, while 28% 17 in Treatment C were degenerated after subjected to a pulse of 1.2 kV/cm for 60 µsec, D and E. The highest rate of development (29%) was achieved in Treatment A that was 3 significantly higher than Treatments C, D and E (Table 2) . We concluded, therefore, that 4 oocyte lysis was caused by both prolonged exposure to electric pulse and culture with 5 cytochalasin D. Interestingly, the cleavage and blastocyst development of oocytes in 6
Treatments A, B, C and D were not different from each other. These values, however, 7
were significantly higher than those in Treatment E (P<0.05), indicating the beneficial 8 effect of cytochalasin D on the development of parthenogenetic oocytes. 9
Experiment 3 10
From the results of Exp. 2, Treatment A (least oocyte lysis) was selected to 11 determine the effect of cytochalasins on embryo development (Table 3 ). There was no 12 difference in the extent of cell lysis between Treatments A to C with various 13 concentrations of cytochalasin D or cytochalasin B (A: 15%; B: 14%; C: 12%; P>0.05). 14 A significantly higher rate of oocyte lysis was found in Treatment D (53%, P<0.05). 15
However, live parthenogenetic oocytes showed similar cleavage rates and blastocyst 16 development among Treatments A and B (P>0.05). In contrast, oocytes in Treatment C 17 gave rise to 38% blastocyst development, better than any cytochalasin B treatments 18 although there was no difference between the cytochalasin D groups. The overall 19 efficiency of blastocyst development in Treatment C was 26% when all oocytes used 20 were taken into consideration and this is the highest among all treatments (Table 3) . As a 21 result, Treatment C in Exp.3 was selected as the optimal regime to parthenogenetically 22 activate bovine oocytes in the next series of experiments. 23
Experiment 4 1
To further determine the effect of repetitive electrical pulses in initiating 2 membrane fusion (30 min apart, applied at 31 hpm) following NT, Treatment A in Exp. 2 3 and Treatment C in Exp. 3 were compared. Data showed neither cleavage (78%, n=228 4 vs. 81%, n=245) nor subsequent development to blastocyst (35%, n=228 vs. 40%, n=245) 5 was influenced by these treatments (P>0.05), a consistently high 40% blastocyst 6 development rate was achieved. 7
Experiment 5 8
With the optimized activation protocol selected (A187/EP/CHX), we conducted a 9 series of NTs with a 2x2 factorial combination of MII vs. pre-activated cytoplasts and 10 embryonic vs. somatic nuclei. The fusion rate was higher in embryonic NT group (A, 11
75% and B, 79%) than that in the somatic NT group (C, 43% and D, 49%) (P<0.05). 12
When the donor nuclei were embryonic cells (Fig 1, E to G) , pre-activation of recipient 13 cytoplasts (Treatment A , Fig 1, F) significantly improved the cloned embryo's ability to 14 undergo cleavage (77% vs. 50%, P<0.05) and blastocyst (Fig 1, G) development (36% 15 vs. 11%, P<0.01) as compared to NT into M II cytoplasm (Table 4) . Interestingly, 16 enucleated oocytes without transfer of donor nuclei can also undergo parthenogenetic 17 development. Some cytoplasts could finish several cell divisions developing to the 8-cell 18 stage before degenerating (data not shown). In contrast, when NT was conducted with 19 cultured somatic cells as donors (Fig 1, I ), metaphase phase (MII) recipient cytoplasm 20 (Fig 1, J) greatly enhanced the extent to which early embryos cleaved (Fig 1, K) 
Analysis of Cell Allocations to TE or ICM 23
As shown in Table 5 , following embryo immunosurgery and differential staining, 1 the total number of nuclei in expanded or hatching blastocysts between parthenogenetic 2 (Fig 1, C, D) and NT (Fig 1, G, H) groups was not significantly different (Table 5 ). The 3 proportion of ICM in different types of blastocysts was not significantly different for 4 embryonic NT, somatic NT, parthenogenetic and frozen in vivo derived embryos, shown 5 as 29%, 33%, 26% and 23%, respectively. Cloned blastocysts developed from an 6 activated cytoplast and an embryonic nucleus (Fig 1, G, H) , or from an MII cytoplast and 7 a somatic nucleus (Fig 1, K, L) showed a similar total cell number and ICM/TE ratio. 8
There was also no difference between NT and parthenogenetic hatched embryos with 9 respect to the percentage of pycnotic cells. However, some parthenogenetic embryos 10 were observed with a sporadic and dislocated distribution of ICM cells (58%, n=38) and 11 an apparent variation in nuclear volume ranging from less to more than the average of the 12 group (45%, n=38). 13
DISCUSSION
14
In the present study, we compared various activation protocols and showed that 15 the development of cloned embryos reconstructed from either embryonic or somatic 16 nuclei require cytoplasts in different activation status for optimal development. In our 17 study with embryonic donor nuclei, nuclear transfer into pre-activated oocytes resulted in 1993). Pulverized PCC may cause the breakage of chromatin and the damage to DNA 5 duplexes in donor nuclei. Therefore, it is essential to synchronize the recipient oocyte 6 and the S phase nucleus during nuclear transfer. Activation of cytoplasts prior to nuclear 7 transfer makes the recipient oocyte transit from MII to G1/S phase, resulting in a 8 universal cytoplasm for the donor nucleus, and allowing continuous DNA synthesis to 9 occur in the S phase donor nucleus (Campbell et al., 1994 (Campbell et al., , 1996 . Although transplanting 10 blastomere nuclei into M II cytoplasts has produced full term development in sheep 11 In the present study, we found that parthenogenetically activated and NT 20 blastocysts have similar TE and ICM cells to those in frozen in vivo embryos, but both 21 parthenogenetic and cloned embryos had reduced total cell numbers, as well as ICM 22 numbers, when compared to those of in vivo produced embryos (Du and Yang, 23 20 unpublished data). It is unknown whether the lower number of cells in the cloned 1 embryos was a result of nuclear reprogramming or was due to the developmental 2 potential of the parthenogenetically activated recipient cytoplasts. 3
In conclusion, more effective activation and parthenogenetic development in 4 cattle was achieved with a combination treatment consisting of calcium ionophore, 5 electric pulse and cycloheximide. Higher in vitro development was achieved when 6 embryonic and somatic donor cells were transferred into pre-activated and MII 7 cytoplasts, respectively. 8 9 10 Values within columns with different superscripts differ, P<0.05. A187, calcium ionophore A23187;CB2.5, cytochalasin B at 2 2.5 µg/ml; CB5, cytochalasin B at 5.0 µg/ml; CD, cytochalasin D; CHX, cycloheximide; EP, electrical pulse; EP90, electrical 3 pulse at 90 µsec. *The oocytes from each group are selected for further culture experiment, and leftover oocytes are fixed and 4 subjected to morphological evaluation (data not shown). The overall blastocyst rates were calculated using total number of 5 oocytes in each treatment. 6 7 8 Table 4 . Development of NT embryos with embryonic and somatic donor nuclei
